A
Aurobindo Pharma
AUROPHARMA Share Price
Healthcare1,304.80
as on 11 Mar 2026 at 15:56
Market Cap
₹75,783 Cr
PE Ratio
21.40
ROCE
15.74%
AUROPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
75,783
PE Ratio
21.40
PB Ratio
2.13
Dividend Yield
-
ROE
10.67%
ROCE
15.74%
Book Value (₹)
603.32
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
| Domestic Institutional Investors (DII) | 25.20% | 26.23% | 26.93% | 27.60% | 27.68% |
| Foreign Institutional Investors (FII) | 16.29% | 15.33% | 14.37% | 14.21% | 13.94% |
| Public Investors | 5.52% | 5.47% | 5.67% | 5.25% | 5.36% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
AUROPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Midcap
BSE Scrip Code
524804
NSE Scrip Name
AUROPHARMA
ISIN
INE406A01037



